News & events

  • Upcoming CRISPR congress Europe in Berlin

    We look forward to sharing with you the results of our new non-integrative MS2-based lentiviral particles for RNA delivery during the upcoming CRISPR congress Europe in Berlin.
  • Fundraising : Vectalys raises 0,9M€

    We are pleased to announce our 0,9M€ fundraising. 
  • Vectalys will attend the ASGCT in Washington

    Vectalys will attend the ASGCT on May 4-7, 2016 in Washington, DC to introduce the next generation of non integrating lentiviral particle for gene and cell therapy applications.